You are here

Evonik commences isophorone facilities in China

News International-French

21 May 2014

The company has commenced an integrated production complex for isophorone and isophorone diamine in Shanghai, China. The company has invested over €100 million in the facilities, which will have an annual output capacity of 50,000 metric tons. 

Construction in the Shanghai Chemical Industry Park (SCIP) took less than two years. Evonik primarily plans to use the output of the new plants to serve customers in the coatings and paint, construction, adhesives, and composite industry in Asia.

Evonik has fifty years of experience with isophorone chemistry and continuously improves its process technologies. So far products based on isophorone (crosslinkers) were being manufactured in Marl and Herne, Germany, and in Mobile, USA.

In addition to the new production complex, Evonik built an application technology service center with state-of-the-art laboratories at the Xinzhuang site in Shanghai. The custom- tailored isophorone solutions will strengthen the competitiveness of Asian customers.

The global market for isophorone and its derivatives grows at a stronger annual rate than global gross domestic product, with Asia showing above-average growth. The demand is particularly driven by the megatrend of resource efficiency. Thus, composites, which are used, for instance, in lightweight construction for automobiles as well as in highly durable wind power stations, offer aboveaverage growth potential.

In addition, isophorone chemistry prolong the life expectancy of heavily used surfaces, which reduces maintenance cost and often makes renovations superfluous. Examples include floor coverings in parking garages, facades exposed to demanding climatic conditions, or ships operating in salty ocean water. Growth projections are also high for environmentally friendly coating technologies, such as UV-curing systems or solvent-free powder coatings. Evonik markets its products of isophorone chemistry globally under the brand names Vestamin, Vestanat, Vestagon and Vestasol.

More information: